Skip to content
type1.science
Phase 2RecruitingNCT05762107

ZT-01 to prevent nocturnal hypoglycemia

Zucara phase 2a crossover study of ZT-01, a somatostatin-receptor antagonist intended to restore glucagon release during lows, for nocturnal hypoglycemia in adults with T1D.

Primary endpoints

  • Incidence of nocturnal hypoglycemia

Results so far

No results posted yet.